NCT07332000 2026-03-17A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene BesadenovecCandel Therapeutics, Inc.Phase 2 Recruiting45 enrolled
NCT05536349 2026-02-24Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-naïve Chronic Lymphocytic Leukemia (CLL) or Richter Transformation (RT)M.D. Anderson Cancer CenterPhase 2 Recruiting60 enrolled